Fueling issues slow anthrax vaccinations in Ghana

TweetHealth officials in Ghana are facing a challenge in the attempt to vaccinate animals against anthrax after an April outbreak, especially the fueling of vehicles to move into communities. Thomas Anyarikeya, the Upper East regional director of veterinary services, said … Read More

FDA approves BioThrax administration schedule change

TweetEmergent BioSolutions, Inc., recently announced that the U.S. Food and Drug Administration has approved its application to alter the administration schedule of BioThrax, the only FDA approved medication to treat anthrax disease pre-exposure. The FDA granted approval to a supplemental … Read More

Government panel debates protecting children from bioterrorism

TweetA presidential panel for the Obama Administration will help to decide if the anthrax vaccine and other stockpiled treatments for bioterrorism should be tested on children. Kathleen Sebelius, the Health and Human Services secretary, said that officials cannot simply assume … Read More

Michigan brownfield tax incentive clears hurdle for Emergent BioSolutions

TweetA $6.4 million brownfield tax incentive for Emergent BioSolutions, Inc., a developer of the anthrax vaccine, successfully cleared a procedural roadblock on Monday after the Lansing City Council held a public hearing on the matter. The incentive would collect new … Read More

USAMRIID scientist nominated for major award

TweetA scientist from the U.S. Army Medical Research Institute of Infectious Diseases located at Fort Detrick, Maryland, was recently nominated for a major award for his work in researching vaccines against bioterror agents. Dr. Arthur Friedlander has been nominated for … Read More

Profectus BioSciences receives grant for Ebola and Marburg vaccine

FDA approves Levaquin for use against pneumonic plague

Emergent BioSolutions’ Fuad El-Hibri named Tech Council of Maryland’s executive of year

New FMD vaccine developed in U.S.

Three companies in pursuit of Ebola vaccine

Emergent BioSolutions, Inc., plans Michigan expansion

Minneapolis-St. Paul to conduct large scale MCM distribution test

HGS rejects GSK takeover offer, eventual sale considered likely

DTRA amends vaccine production solicitations

J&J plague treatment could gain fast FDA approval

PharmAthene secures $7.5 million in senior secured credit facilities

El-Hibri leaves lasting legacy of success at Emergent BioSolutions, Inc.

Louisville postal carrier to carry antibiotics in the event of bioattack

Antibody-based therapies shown to protect against Ebola, Marburg

Skin vaccinations may provide greater bioweapon protection

Immunovaccine begins collaboration to create next-gen biodefense vaccines

U.S. testing new rapid response vaccine-delivery platform

ITT Exelis and Altapure announce new disinfection system

Immunovaccine enters into biodefense vaccine development collaboration

Soligenix demonstrates thermostabilization success

HHS enters contract for novel biowarfare antibiotic

SIPP International Industries acquires new bioterror fighting tech.